IL202272A0 - Process for forming solid oral dosage forms of angiotensin ii receptor antagonists - Google Patents

Process for forming solid oral dosage forms of angiotensin ii receptor antagonists

Info

Publication number
IL202272A0
IL202272A0 IL202272A IL20227209A IL202272A0 IL 202272 A0 IL202272 A0 IL 202272A0 IL 202272 A IL202272 A IL 202272A IL 20227209 A IL20227209 A IL 20227209A IL 202272 A0 IL202272 A0 IL 202272A0
Authority
IL
Israel
Prior art keywords
angiotensin
dosage forms
oral dosage
receptor antagonists
solid oral
Prior art date
Application number
IL202272A
Original Assignee
Dexcel Ltd
Schlinger Ron
Avramoff Avi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2008/000732 external-priority patent/WO2008149338A2/en
Application filed by Dexcel Ltd, Schlinger Ron, Avramoff Avi filed Critical Dexcel Ltd
Priority to IL202272A priority Critical patent/IL202272A0/en
Publication of IL202272A0 publication Critical patent/IL202272A0/en

Links

IL202272A 2007-06-06 2009-11-22 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists IL202272A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL202272A IL202272A0 (en) 2007-06-06 2009-11-22 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92494107P 2007-06-06 2007-06-06
PCT/IL2008/000732 WO2008149338A2 (en) 2007-06-06 2008-05-29 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
IL202272A IL202272A0 (en) 2007-06-06 2009-11-22 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists

Publications (1)

Publication Number Publication Date
IL202272A0 true IL202272A0 (en) 2010-06-16

Family

ID=42263547

Family Applications (1)

Application Number Title Priority Date Filing Date
IL202272A IL202272A0 (en) 2007-06-06 2009-11-22 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists

Country Status (1)

Country Link
IL (1) IL202272A0 (en)

Similar Documents

Publication Publication Date Title
EP2167049A4 (en) Tamper resistant lipid-based oral dosage form for opioid agonists
EP2215048A4 (en) P2x3 receptor antagonists for treatment of pain
EP2244575A4 (en) Angiotensin ii receptor antagonists
EP2215049A4 (en) P2x3, receptor antagonists for treatment of pain
IL208895A0 (en) Nmda receptor antagonists for the treatment of neuropsychiatric disorders
EP2358371A4 (en) P2x3, receptor antagonists for treatment of pain
HU0600816D0 (en) Method of alcohol-induced dose dumping for opioid sustained release oral dosage forms
HRP20171421T1 (en) Solid dosage forms of bendamustine
ZA201001597B (en) Octahydropentalene compounds as chemokine receptor antagonists
EP2350024A4 (en) Improved process for the preparation of endothelin receptor antagonists
EP2410857A4 (en) P2x3, receptor antagonists for treatment of pain
HK1136302A1 (en) Progesterone receptor antagonists
HUS1800044I1 (en) Angiotensin II receptor antagonist for the treatment of hypertension in cats
EP2427430A4 (en) 5-oxo-ete receptor antagonist compounds
EP2410858A4 (en) P2x3 receptor antagonists for treatment of pain
HK1160642A1 (en) Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists via
IL213270A0 (en) Oral dosage forms of bendamustine
ZA200904479B (en) Nitroderivatives as angiotensin II receptor antagonists
IL200380A0 (en) Mineralcorticoid receptor antagonists for the treatment of endometriosis
IL205432A0 (en) Method of identigfying safe nmda receptor antagonists
EP2250168A4 (en) Angiotensin ii receptor antagonists
IL202272A0 (en) Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
EP2291076A4 (en) Angiotensin ii receptor antagonists
ZA200906849B (en) Mineralcorticoid receptor antagonists for the treatment of endomertriosis
GB0701632D0 (en) MET receptor antagonists